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RAS signalling through PI3-Kinase controls cell
migration via modulation of Reelin expression
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RAS signalling through phosphoinositide 3-kinase (PI3-Kinase) has been shown to have an
essential role in tumour initiation and maintenance. RAS also regulates cell motility and
tumour invasiveness, but the role of direct RAS binding to PI3-Kinase in this remains
uncertain. Here, we provide evidence that disruption of RAS interaction with PI3-Kinase p110a
decreases cell motility and prevents activation of Rac GTPase. Analysis of gene expression in
cells lacking RAS interaction with p110a reveals increased levels of the extracellular matrix
glycoprotein Reelin and activation of its downstream pathway resulting in upregulation of
E-cadherin expression. Induction of the Reelin/E-cadherin axis is also observed in Kras
mutant lung tumours that are regressing due to blockade of RAS interaction with PI3-Kinase.
Furthermore, loss of Reelin correlates with decreased survival of lung and breast cancer
patients. Reelin thus plays a role in restraining RAS and PI3-kinase promotion of cell motility
and potentially tumour metastasis.
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C
ell migration is a complex highly coordinated process that
is essential for many diverse biological processes in
animals, including embryonic morphogenesis, immune
surveillance, tissue homoeostasis and wound healing. Errors
during this process have important consequences, including
mental retardation, vascular disease, tumour formation and
metastasis. A better understanding of the mechanisms by which
cells migrate may lead to the development of novel therapeutic
strategies for controlling the invasive behaviour of tumour cells1–3.
Acquisition of an increased migratory phenotype, accompanied
by extensive remodelling of the actin cytoskeleton is one of the
first requirements in metastasis formation. Oncogenic activation
of RAS has been implicated in facilitating almost all aspects of the
malignant phenotype4,5. Oncogenic RAS contributes to this
process by inducing alterations in cell–cell and cell–matrix
interactions, and the acquisition of a migratory phenotype. The
perturbation of cell–cell contacts by oncogenic RAS is
accomplished through the targeting of the molecular machinery
that maintains intercellular adhesion junctions, including the
E-cadherin receptor and its associated cytoplasmic protein
b-catenin6,7. Also, oncogenic RAS directly contributes to the
enhanced motility of cancer cells by affecting pronounced
changes in the polymerization, organization and contraction of
actin; the polymerization and/or stability of microtubules; and
the transcriptional regulation of mitogenic gene products4,8.
Collectively, these changes establish the front-rear asymmetry
that is required for cell migration.
Although a significant number of studies have analysed the role
of Rho family GTPase signalling pathways in RAS-induced
transformation, relatively little is known about the differential
regulation of Rho GTPases by RAS oncogenes, or their
subsequent contribution to oncogene-specific cell migration
properties. It is well known that extracellular signal-regulated
kinase signalling is important for cell motility through Rho
GTPases8,9. The PI3-Kinase pathway is also involved in Rho
family signal transduction, affects cell migration10,11 and has been
implicated in metastasis of RAS mutant lung tumours12.
Oncogenic RAS is required for both induction and maintenance
of epithelial to mesenchymal transition, mainly through its
downstream effector extracellular signal-regulated kinase and
increased cell migration and invasion mediated by Rac1 (refs 13–15).
However, the specific role that RAS plays in tumour invasion and
metastasis or the main effector pathways through which RAS
contributes to metastasis formation are still poorly understood.
Defining the precise modes by which RAS-responsive pathways
affect metastatic capacity awaits an improved understanding of
the context-dependent outcome of their coordinated activation.
In this study, we undertook an analysis of the migration of
mouse embryo fibroblasts derived from a mouse model in which
RAS cannot interact with PI3-Kinase due to the introduction of
two point mutations (T208D and K227A) in the RAS-binding
domain (RBD) of the endogenous Pik3ca gene16. Our
experimental data show that RAS, through its interaction with
PI3-Kinase, regulates migration of cells in response to several
growth factors by regulating Rac activation. We also identify a key
role for Reelin (RELN) as a regulator of cell migration
downstream of RAS-PI3-Kinase signalling and show that this
interaction controls Reelin messenger RNA (mRNA) stability,
thus regulating its expression. Activation of the Reelin
downstream pathway prevents cells from migrating and results
in the upregulation of E-cadherin, thereby impacting on cell–cell
interaction. These results provide a better understanding of how
PI3-Kinase signalling contributes to RAS-driven invasiveness and
metastatic potential and may lead to the development of more
effective therapies that prevent metastatic spread of primary
tumours.
Results
Disruption of RAS-PI3-Kinase binding impairs cell motility.
We have previously reported the generation of a mouse model in
which the interaction between RAS and PI3-Kinase is disrupted
by two point mutations on the RBD of the endogenous Pik3ca
gene (T208D and K227A)16. Here we use mouse embryonic
fibroblasts (MEFs) isolated from Pik3caRBD mice to investigate
how signalling through the RAS-PI3-Kinase axis regulates cell
motility.
First, we explored whether the disruption of the RAS-PI3-
Kinase interaction affected cell migration. The increase in
migration speed observed in response to foetal bovine serum
(FBS), platelet derived growth factor (PDGF) or fibroblast growth
factor 2 (FGF2) stimulation was similar in Pik3caWT and
Pik3caRBD MEFs (Fig. 1a, and Supplementary Fig. 1a,b).
However, the migration speed of the Pik3caRBD MEFs was not
increased by epidermal growth factor (EGF) (Fig. 1b), hepatocyte
growth factor (HGF) (Fig. 1c) or insulin treatment (Fig. 1d),
although these were effective on Pik3caWT cells. In all cases, the
increase in migration speed was restored on introduction of a
wild type (WT) p110a to cells, confirming that the defect was due
to the disruption in RAS-PI3-Kinase signalling.
We also investigated whether the RBD mutation had an impact
on the migration speed in response to oncogenic RAS (HRAS
V12) expression, using a tamoxifen-inducible fusion protein of
activated RAS with the hormone-binding domain of the
oestrogen receptor. Although induction of oncogenic RAS had
a great impact on the migration of Pik3caWT cells, Pik3caRBD
cells were not affected and migration was not increased (Fig. 1e).
Similar results were obtained when a constitutively active
oncogenic RAS was expressed (Supplementary Fig. 1c).
To confirm that the migration phenotype of Pik3caRBD cells
treated with EGF was due to a defect in PI3-Kinase signalling, we
investigated the effect of treating both WT and RBD-mutant cells
with a specific PI3-Kinase p110a inhibitor (BYL-719) or with a
pan-PI3-Kinase inhibitor (PI-103). Both inhibitors led to
abrogation of the effect of EGF on migration of Pik3caWT MEFs
(Fig. 1f and Supplementary Fig. 1d), but had no additional effect
in migration of Pik3caRBD cells. MAPK signalling pathway is
another of the main downstream effectors of RAS signalling. We
wondered if its inhibition with the MEK inhibitor trametinib
would have an effect in cell migration. Pik3caWT cells treated with
trametinib showed a decrease in EGF-induced migration but were
still able to migrate (Fig. 1e). Migration of Pik3caRBD cells was
not affected by MEK inhibition. All together these results suggest
that PI3K is the main RAS-effector pathway controlling cell
migration and that p110a is the main PI3-Kinase isoform
involved in the regulation of cell migration, although it is likely
that other mechanisms may also play a role.
Next we measured the ability of EGF to activate RAS in both
wild type and RBD-mutant cells. Our results showed that
although basal RAS activity is lower in the RBD-mutant cells,
RAS is activated normally in response to EGF in both Pik3caRBD
and Pik3caWT MEFs (Fig. 1g), indicating that the migration
defect in Pik3caRBD cells is not due to a defect in RAS activation.
We have previously shown that Pik3caRBD MEFs have a defect
in Akt activation in response to EGF and HGF, but not in
response to PDGF or FBS (ref. 16). To investigate whether the
RAS-PI3-Kinase interaction could be regulating cell motility via
Akt signalling, we next determined whether Pik3caRBD cells
expressing inducibly activatable Akt (ER-myrAkt) could migrate
in response to EGF stimulation. Our results show that restoring
Akt signal in the Pik3caRBD cells also restore the defect in
migration (Fig. 1h). It was noticeable that migration was partially
restored even before adding 4-hydroxytamoxifen (4-HT) to the
cells. Thus, we checked if the construct was leaky by analysing
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Figure 1 | Removal of RAS Interaction with p110a impairs cell motility. (a–d) Random migration of Pik3caWT, Pik3caRBD and Pik3caRBD containing a
WT p110a was analysed by time-lapse video microscopy and cell tracing in the presence or absence of (a) PDGF (20 ngml 1); (b) EGF (20 ngml 1);
(c) HGF (10 ngml 1); (d) Insulin (100 ngml 1). Cells were imaged at 10min intervals for 18 h. Graphs show migration tracks obtained from 90 cells in
each experimental condition. The data are represented as a box and whisker plot in which the box shows the interquartile range that contains values
between 25th and 75th percentile. The line inside the box shows the median. The two whiskers show adjacent values. The upper adjacent value (upper
mark) is the value of the largest observation that is less than or equal to the upper quartile plus 1.5 the length of the interquartile range. Analogously the
lower adjacent value (lower mark) is the value of the smallest observation that is greater than or equal to the lower quartile less 1.5 times the length of
interquartile range. Analysis of variance (ANOVA) statistical analysis was performed with starved cells used as reference for each condition (NS, not
significant; **Po0.01; ***Po0.001). (e) Random migration assays of Pik3caWT and Pik3caRBD cells containing ER-RAS V12 (tamoxifen-inducible H-RAS
V12) treated with 4-hydroxytamoxifen (TX) or vehicle control. ANOVA statistical analysis was performed with starved cells used as reference for each
condition (NS, not significant; ***Po0.001). Box and whisker plot was generated as indicated for a. (f) Random migration of Pik3caWTand Pik3caRBD cells
was analysed by time-lapse video microscopy and cell tracing in the presence or absence of EGF (20 ngml 1) and the p110a specific PI3-kinase inhibitor
BYL-719 (500nM). Assay was carried out as described for a. ANOVA statistical analysis was performed with starved cells used as reference for each
condition (NS, not significant; ***Po0.001). Box and whisker plot was generated as indicated for a. (g) Pik3caWT (filled bars) and Pik3caRBD (empty bars)
MEFs were stimulated with EGF (20ngml 1) for the indicated time periods. RAS-GTP activity was established in pull-down assays using GST-RBD of Raf
(GST-RafRBD). Both total lysates and proteins bound to GST-RafRBD were analysed by western blot to detect RAS. Lower panel, quantitation of pull-down
assays. (h) Random migration of Pik3caWT, Pik3caRBD and Pik3caRBD cells containing ER-MyrAkt was analysed by time-lapse video microscopy and cell
tracing in the presence or absence EGF (20 ngml 1) and 4-hydroxytamoxifen (TX). ANOVA statistical analysis was performed with starved cells used as
reference for each condition (NS, not significant; **Po0.01; ***Po0.001). Box and whisker plot was generated as indicated for a.
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Akt phosphorylation and one of its targets, S6 phosphorylation.
Although we were not able to detect any Akt activity in the cells
prior 4-HT addition, we observed that there was an increase in
p-S6 in mutant cells containing the ER-myrAkt construct in the
absence of 4-HT prior EGF stimulation (Supplementary Fig. 1f),
suggesting that the construct might have some basal activity.
RAS-PI3-Kinase pathway regulates cell polarity and invasion.
Migration is a polarized cellular process in which cells display a
protrusive front edge that opposes a retracting trailing edge.
Without this polarity, cells would lack the ability to move in a
specific direction3,17,18. To elucidate whether the RAS-PI3-Kinase
interaction has a role in establishing cell polarity, we performed
wound-healing assays to measure persistence of migration
direction in response to EGF and FBS stimulation. We
observed that Pik3caRBD cells migrate in a disorderedly
manner, whereas Pik3caWT cells migrate with a greater
directional persistence towards the wound area (Fig. 2a).
Directed cell migration requires cell polarization and adhesion
turnover, in which the actin cytoskeleton and microtubules play
critical roles. Microtubule network polarity and stabilization
controls the establishment and maintenance of the spatial and
temporal coordination of migration events and is therefore the
key to persistent directed migration19–21. We investigated
whether the lack of directional movement of RBD-mutant cells
was due to a defect in the regulation of microtubule stability.
Protein levels of a-tubulin measured by western blot and
immunofluorescence were similar in Pik3caWT and Pik3caRBD
cells (Supplementary Fig. 2a,b). Protein levels of glutamylated
tubulin, one of the major modifications to stabilize microtubules,
were also similar in both cell lines. However we found that
Pik3caRBD cells had an increase in the acetylation of a-tubulin,
the other main microtubule stabilization process (Supplementary
Fig. 2a). This difference was neither dependent nor affected by
EGF treatment or other growth factors (Supplementary Fig. 2c).
Immunofluorescence studies also revealed differences in the
localization of acetylated a-tubulin, which in the Pik3caRBD cells
is not found in the plasma membrane but rather in the
perinuclear region (Supplementary Fig. 2b). We were able to
partially reverse the increase in a-tubulin acetylation of mutant
cells when we re-expressed a wild-type version of 110a in these
cells (Supplementary Fig. 2d), thereby confirming that this
difference is a consequence of disrupting the RAS-PI3-Kinase
interaction.
Invasive migration is a fundamental aspect of cellular processes
such as angiogenesis, embryonic development, immune response,
metastasis and invasion of cancer cells. We investigated whether
interaction between RAS and PI3-Kinase is required for the
ability of cells to invade through a collagen matrix towards a
growth factor using a previously described assay22. We found that
although Pik3caWT cells were able to invade collagen towards
EGF, Pik3caRBD cells stayed mostly in the bottom of the plate,
indicating a deficiency in their invasive ability (Fig. 2b). Similar
results were obtained in transwell assays in which cells have to
invade through a matrigel layer. The invasive defect displayed by
Pik3caRBD cells in this assay could be rescued by expression of a
WT p110a (Fig. 2c).
Rac-GTPase activity is impaired in Pik3caRBD cells. Cell
migration requires that Rac GTPases promote formation of actin
polymers at the cell leading edge18,23,24. We investigated whether
disruption of RAS signalling through PI3-Kinase had an impact
on Rac activity and found a decrease in Rac-GTP levels in
Pik3caRBD cells in response to EGF (Fig. 3a). We obtained similar
results with an independent pair of MEF preparations, indicating
that this difference is not due to a clonal or immortalization
artefact (Supplementary Fig. 3a). Interestingly, no differences in
Rac-GTP levels were found in response to stimulation with PDGF
(Fig. 3b).
We then investigated whether the impairment in Rac activity
was causing the migration defect observed in the Pik3caRBD cells
and found that the EGF-dependent induction of migration of
Pik3caWT fibroblasts was abrogated by treatment with the Rac
inhibitor EHT-1864 (Fig. 3c). This did not have a significant
effect on the slower migration of Pik3caRBD cells. Furthermore,
the migration defect in Pik3caRBD cells was restored after
expression of an active Rac construct (RacV12; Fig. 3d).
Additionally, we observed a defect in Rac accumulation at the
leading edge of RBD-mutant fibroblasts after EGF stimulation
(Fig. 3e). These results suggest that RAS signalling through
PI3-Kinase is required to mobilize Rac at the leading edge of
migrating cells during EGF-induced cell motility, a key event for
the establishment of cell polarity during migration3,17,18.
We also looked for differences in the actin cytoskeleton after
disruption of the RAS-PI3-Kinase signalling. However, we did not
find significant differences between Pik3caWT and Pik3caRBD cells
(Supplementary Fig. 3b).
Taken together, our results suggest that RAS signalling through
PI3-Kinase regulates EGF-induced cell motility by activating Rac
and keeping it at the leading edge of migrating cells.
RAS-PI3-Kinase interaction regulates Reelin expression. To
find regulators of migration whose expression may be controlled
by RAS-PI3-Kinase signalling we performed expression analysis
of non-stimulated Pik3caRBD and Pik3caWT mouse embryo
fibroblasts using commercial oligonucleotide microarrays. The
plot in Fig. 4a highlights gene probe sets that are differentially
expressed (FDR¼ 0.05) between Pik3caWT and Pik3caRBD cells.
Supplementary Table 1 lists the top 50 probe sets that were
upregulated, and Supplementary Table 2 the top 50 probe sets
that were downregulated, in the Pik3caRBD cells when compared
with their WT counterparts. We observed that Reelin (RELN)
expression was highly upregulated in the Pik3caRBD cells, with
nine of the top 10 upregulated reporters being Reelin sequences.
We used real-time quantitative PCR to confirm that Reelin
expression was upregulated in the Pik3caRBD cells (Fig. 4b).
Importantly, RELN expression levels were reduced to normal
levels by expression of WT p110a (Fig. 4b) and also when Akt
signalling was restored in the Pik3caRBD fibroblasts (Fig. 4c).
About 80% of the mutations in the coding sequence of PIK3CA
map to three hot spots. Two of the hot spots, represented by the
single amino acid substitutions E542K and E545K, are localized
in the helical domain of the protein, the third, represented by
the H1047R substitution, resides in the kinase domain25.
We hypothesized that active PIK3CA would downregulate
RELN expression in our Pik3caRBD cells. Stable expression
of PIK3CAH1047R in Pik3caRBD cells significantly decreased
Reelin expression to levels compared with Pik3caWT cells
(Supplementary Fig. 4a). Additionally, transwell assays showed
that expression of PIK3CAH1047R in Pik3caRBD cells rescued the
defect in migration (Supplementary Fig. 4b). All together, our
results suggested that p110a regulates expression of Reelin.
Reelin is a secreted extracellular matrix glycoprotein that helps
regulate processes of neuronal migration and positioning in the
developing brain by controlling cell–cell interactions. In the adult
brain it modulates synaptic plasticity by enhancing the induction
and maintenance of long-term potentiation. It also regulates
the continuing migration of neuroblasts generated in adult
neurogenesis sites26–28. Reelin expression is lost in some cancers
such as breast or pancreatic cancers and is associated with a poor
prognosis29,30.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11245
4 NATURE COMMUNICATIONS | 7:11245 |DOI: 10.1038/ncomms11245 | www.nature.com/naturecommunications
We investigated whether the upregulation of RELN expression
played a role in the migration defect observed in the Pik3caRBD
cells and found that knocking down RELN expression with
short interfering RNA restored the EGF-induced increase in
migration in Pik3caRBD cells (Fig. 4d and Supplementary Fig. 4c).
Moreover, addition of purified recombinant Reelin to the
medium of Pik3caWT cells abrogated the increase in migration
induced by EGF (Fig. 4e) but not by PDGF (Supplementary
Fig. 4d).
We also found that RELN expression was notably decreased
after expression of a constitutively activated Rac (RacV12) in
Pik3caRBD cells (Fig. 4f) and that treatment with the Rac inhibitor
EHT-1864 increased the expression of RELN in the Pik3caWT
cells (Supplementary Fig. 4e). Interestingly, Rac activation by EGF
in Pik3caWT cells was abrogated by the addition of purified
recombinant Reelin to the medium (Fig. 4g). This suggests that
there is a reciprocal regulation between Rac and Reelin, with
mutual negative feedback loops. The defect in EGF-induced
migration in PI3-Kinase RBD mutant cells is due to changes in
expression of RELN and impairment of Rac activity.
We then aimed to investigate if activation of Rac or Reelin
pathway were involved in the increased acetylation of micro-
tubules. Knockdown of RELN in Pik3caRBD cells did not restore
levels of acetylated a-tubulin (Supplementary Fig. 4f). However
expression of constitutively active Rac in Pik3caRBD cells
decreased the levels of acetylated tubulin in Pik3caRBD cells to
0
200
100
300
–400
–200
–300
–100
0
200
100
300
–400
–200
–300
–100
0
10
0
30
0
–
40
0
–
20
0 0
10
0
30
0
–
40
0
–
20
0 0
10
0
30
0
–
40
0
–
20
0
Starved EGF FBS
Starved
EGF 
In
va
si
on
 a
s 
pa
rt 
of
 1
00
0.2
0.4
0.6
0.8
1.0
1.2
1.4
**
***
Starved EGF
0.10
0.05
0.15
0.20
0.25
O
D 
(56
5 n
m)
Starved EGF
Starved EGF FBS Starved EGF FBS
1.05
1.00
0.95
0.90
0.85
0.80
0.75
0.70
NS
NS
**
** ***
Pe
rs
is
te
nc
e 
(ra
nd
om
 un
its
)
Pik3caRBD
Pik3caRBD + p110α WT
Pik3caWT
Starved FBS
1.5
0.5
1.0
Pik3caRBD
Pik3caRBD + p110α WT
Pik3caWT
O
D 
(56
5 n
m)
Pik3caRBD
Pik3caWT
Pik3caRBDPik3caWT
Pik3caRBDPik3caWT
Pik3caRBDPik3caWT Pik3caRBDPik3caWT
NS
NS
***
NS
NS
NS
**
NS
15
0 
μm
a
b
c
Figure 2 | Disruption of RAS interaction with PI3-Kinase disturbs cell polarity and invasion. (a) Wounded Pik3caWT and Pik3caRBD MEFs monolayers
were allowed to migrate for 18 h in the presence or absence EGF (20 ngml 1) or FBS (10%). Migration was analysed by time-lapse video microscopy. For
each condition 90 cells were tracked and persistence in the directionality of migration was analysed using Mathematica software. Analysis of variance
(ANOVA) statistical analysis was performed with starved cells used as reference for each condition (NS, not significant; **Po0.05; ***Po0.005).
(b) Invasion of Pik3caWTand Pik3caRBD cells in a collagen I matrix in the presence or absence of EGF (0.5mgml 1). Stacks are acquired from the bottom of
the well over 150 mm upward. Invasion through the collagen layer was monitored in a confocal microscope and analysed using Mathematica software.
ANOVA statistical analysis was performed (**Po0.05; ***Po0.005). (c) Invasion of Pik3caWT, Pik3caRBD and Pik3caRBD WT p110a MEFs in transwells
containing a layer of matrigel (growth factor reduced matrigel). Invasion was measured in either 0.2% FBS (starved), EGF (50ngml 1) or FBS (10%).
Invasive cells (on the lower part of the transwell, attached to the membrane) were stained with crystal violet and then lysed using acetic acid. Assays were
carried out in triplicate, with error bars indicating s.d. The results of two different experiments are shown. Error bars indicate s.d. (Significance using
Student’s t-test. NS, not significant; **Po0.05; ***Po0.005).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11245 ARTICLE
NATURE COMMUNICATIONS | 7:11245 | DOI: 10.1038/ncomms11245 | www.nature.com/naturecommunications 5
Starved
EGF
2 min
EGF EGF EGF EGF
+ EHT1864 + EHT1864
10
15
20
25
30
Sp
ee
d 
(μm
 h
–
1 )
Sp
ee
d 
(μm
 h
–
1 )
0 30 180 0 30 180 Secs PDGF
Rac-GTP
Total Rac
0
Time PDGF stimulation
(seconds)
**
Rac dapi
Pik3caWT
Pik3caRBD
Pik3caRBDPik3caWT
Pik3caRBDPik3caWT
Pik3caRBDPik3caWT
0 30 180 0 30 180 Secs EGF
Rac-GTP
Total Rac
0 30 180
Pik3caRBDPik3caWT
Pik3caWT
Pik3caRBD
Time EGF stimulation
(seconds)
NS NS
NS
EGF
5 min
Starved EGF Starved EGF Starved EGF
RBD-mutant RBD-mutant
+RacV12
10
15
20
25
30
35
**
*
NS
Pik3caWT Pik3caRBD
NS NS
**
NS NS
NS
21
21
kDa
21
21
kDa
R
ac
-G
TP
/to
ta
l R
ac
1.5
1.0
0.5
R
ac
-G
TP
/to
ta
l R
ac
2.0
1.5
1.0
0.5
18030
Starv. Starv.Starv.Starv.
Wild type
a b
c d
e
Figure 3 | Defects in Rac-GTPase activation in Pik3caRBD cells. (a) MEFs were stimulated with EGF (20ngml 1) for the indicated time periods. Rac-GTP
activity was established in pull-down assays using GST-PBD of PAK1 (GST-PBD). Both total lysates and proteins bound to GST-PBD were analysed by
western blot to detect Rac. (b) MEFs were stimulated with PDGF (20 ngml 1) for the indicated time periods and pull-down assays and analysis of the
results were done in the same way as described for previous panel. (c) EGF-induced random migration of Pik3caWT and Pik3caRBD cells was analysed by
time-lapse video microscopy and cell tracing in the presence or absence of the Rac inhibitor EHT-1864 (5mM). Analysis of variance (ANOVA) statistical
analysis was performed with starved cells used as reference for each condition (NS, not significant; **Po0.01). Box and whisker plot was generated as
indicated for Fig. 1a. (d) EGF-induced random migration of Pik3caWT, Pik3caRBD and Pik3caRBDþRacV12 cells was analysed by time-lapse video microscopy
and cell tracing. ANOVA statistical analysis was performed with starved cells used as reference for each condition (NS, not significant; **Po0.01).
Box and whisker plot was generated as indicated for Fig. 1a. (e) Pik3caWT and Pik3caRBD cells were stimulated with EGF for the denoted time points.
immunofluorescence (IF) to detect Rac accumulation in the plasma membrane was performed. DAPI co-staining was carried out to distinguish individual
cells. Scale bar, 10mm. White squares indicate part of the membrane magnified in the right hand images. Arrows indicate direction of cell movement.
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levels comparable with Pik3caWT cells (Supplementary Fig. 4g).
These data suggest that the increased acetylation of microtubules
is dependent on Rac signalling but the mechanism by which this
regulation happens is independent of Reelin pathway.
It has been described that the PI3-Kinase pathway regulates the
activity of RNA-binding factors that stabilize mRNA, thus
controlling gene expression31–33. The 30-UTR region of the
RELN gene has AU- and U-rich sequences (Supplementary
Fig. 4h), suggesting that its expression might be regulated through
mRNA stabilization. Indeed, disrupting the interaction between
RAS and PI3-Kinase leads to an increase in the stability of RELN
mRNA in the Pik3caRBD cells that can be reverted by expression
of WT p110a or AKT (Fig. 4h).
Reelin upregulates E-cadherin in Pik3caRBD cells. RELN binds
to very low density lipoprotein receptor (VLDLR) and apolipo-
protein E receptor 2 (ApoER2) (both from the low-density
lipoprotein family), leading to induction of phosphorylation of
the cytoplasmic adaptor protein Dab1 on tyrosine 198 (refs 34–
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Figure 4 | Reelin expression is regulated by RAS-PI3-Kinase pathway and is involved in migration. (a) Graphical display of statistical analysis performed
to identify genes undergoing significant changes of expression in Pik3caRBD cells as compared with wild-type counterparts. Statistically significant probes
are shown in light blue (0.05 fdr). Reln reports are shown in red. (b) RNA from steady-state (st-st), serum-starved or EGF-treated (20 ngml 1) fibroblasts
was obtained and Reln mRNA levels measured by quantitative PCR (qPCR). Actin expression was used as an internal control for normalization.
Independent triplicates were used for each time point. Error bars indicate mean±s.e.m. (c) Levels of Reln expression were measured by qPCR in Pik3caRBD
cells containing an inducible active Akt construct (ER-MyrAKT) in the presence or absence of 4-hydroxytamoxifen (TX; 100nM). Actin expression was
used as an internal control for normalization. Independent triplicates were used for each time point. Error bars indicate mean±s.e.m. (d) Random migration
after Reln silencing in Pik3caRBD cells. Migration was analysed by time-lapse video microscopy and cell tracing in the presence or absence of EGF
(20ngml 1). Box and whisker plot was generated as indicated for Fig. 1a.ANOVA statistical analysis was performed with starved cells used as reference
for each condition (NS, not significant; **Po0.01; ***Po0.001). (e) Recombinant Reln (1 mgml 1) was added to the media of Pik3caWTand Pik3caRBD cells
and random migration was then analysed in the same way as described for previous panel. (f) Reln expression levels in Pik3caWT, Pik3caRBD and Pik3caRBD
RacV12 cells. Actin expression was used as an internal control for normalization. Independent triplicates were used for each time point. (g) Rac pull-down
analysis in the presence of recombinant Reln. Recombinant Reln was added to the media of Pik3caWT MEFs and then Rac-GTP activity was determined in
pull-down assays using GST-PBD of PAK1 (GST-PBD). Both total lysates and proteins bound to GST-PBD were analysed by western blot to detect Rac. (h)
Representative graph showing Reln mRNA half-life. Pik3caWT, Pik3caRBD, Pik3caRBD p110a WT and Pik3caRBD ER-myrAkt (þTX) cells were treated with
actinomycin D and levels of Reln mRNA were determined by qPCR at the displayed time points. Actin expression was used as an internal control for
normalization. Independent triplicates were used for each time point.
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36). Dab1 is, therefore, the initial effector of the Reelin-signalling
cascade. We wondered if knockdown of Dab1 would have an
effect in migration of our cells. Random migration assays showed
that silencing of Dab1 reverted the migration defect of Pik3caRBD
cells (Fig. 5a and Supplementary Fig. 5a).
Reelin, via Dab1 activation, activates Rap1 (ref. 37), so we
checked whether silencing of Rap1 also reverted the migratory
defect of Pik3caRBD cells. Random migration assays confirmed
the involvement of Rap1 in RAS-PI3-Kinase induced migration
(Fig. 5b and Supplementary Fig. 5b).
Rap1 controls cell adhesion by regulating two prominent
classes of adhesion receptors, integrins and cadherins38,39. We
found that in Pik3caRBD cells E-cadherin (Cdh1) levels were
higher than in their wild-type counterparts and that knocking
down p110a expression in the Pik3caWT cells resulted in
increased E-cadherin expression (Fig. 5c). FACS analysis
confirmed an increase in membrane-associated E-cadherin in
Pik3caRBD cells (Supplementary Fig. 5c). Similarly, silencing of
RELN, Dab1 or Rap1 in Pik3caRBD and Pik3caWT cells decreased
Cdh1 levels (Fig. 5d and Supplementary Fig. 5d). Cdh1 levels were
rescued by restoring Rac activation in Pik3caRBD cells (Fig. 5e).
Additionally, knockdown of Cdh1 also increased migration in
response to EGF in Pik3caRBD cells (Fig. 5f and Supplementary
Fig. 5e).
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Figure 5 | The Reelin pathway regulates migration in Pik3caRBD cells. (a) Random migration after dab1 silencing in Pik3caRBD cells. Migration was
analysed by time-lapse video microscopy and cell tracing in the presence or absence of EGF (20 ngml 1). Box and whisker plot was generated as indicated
for Fig. 1a. Analysis of variance (ANOVA) statistical analysis was performed with starved cells used as reference for each condition (NS, not significant;
***Po0.001). (b) Random migration after Rap1 silencing in Pik3caRBD cells. Migration assay was performed and analysed as described for previous
panel. ANOVA statistical analysis was performed with starved cells used as reference for each condition (NS, not significant; **Po0.01; ***Po0.001).
(c) Representative graph showing Cdh1 expression levels in Pik3caWT, Pik3caRBD and Pik3caWTcells 72 h after silencing of p110a. Actin expression was used
as an internal control for normalization. The assay was performed three times and each time it was performed in triplicates. Error bars indicate
mean±s.e.m. (Significance using Student’s t-test ***Po0.001). (d) Representative graph showing Cdh1 expression levels in Pik3caRBD cells 72 h after
silencing of Reln, Dab1 or Rap1. Actin expression was used as an internal control for normalization. The assay was performed three times and each time it
was performed in triplicates. Error bars indicate mean±s.e.m. (e) Representative graph showing Cdh1 expression levels in Pik3caWT, Pik3caRBD and
Pik3caRBD RacV12 cells. Actin expression was used as an internal control for normalization. The assay was performed three times and each time it was
performed in triplicates. Error bars indicate mean±s.e.m. (Significance using Student’s t-test ***Po0.001). (f) Random migration after Cdh1 silencing in
Pik3caRBD cells. Migration assay was performed and analysed as described for a). Box and whisker plot was generated as indicated for Fig. 1a. ANOVA
statistical analysis was performed with starved cells used as reference for each condition (NS, not significant; **Po0.01).
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Pik3caRBD-derived lung tumours have increased Reln and Cdh1.
We have shown that the RELN pathway is regulated by
RAS-PI3-Kinase interaction in mouse embryo fibroblasts. Is this
regulation also occurring in vivo and could it contribute to the
regulation of migration in tumoral cells? To investigate this
hypothesis we took advantage of an inducible mouse model
developed in our lab in which one of the p110a alleles can be
conditionally deleted and the other p110a allele has point
mutations in the RBD (Pik3caRBD/flox). These mice also have a
conditional Cre recombinase (Cre-ERT2) allele targeted to the
ubiquitously expressed Rosa26 locus. These mice were bred with
KrasLA2 mice13, which have a mutated copy of KRAS, so that they
spontaneously developed lung adenocarcinomas. By feeding them
with tamoxifen we can remove the floxed allele and Pik3caWT/
or Pik3caRBD/ are expressed. Pik3caRBD/ mice present fewer
and smaller tumours than their Pik3caWT/ counterparts and the
incidence of higher grade tumours was also reduced40 according
to standard histopathological characteristics41. We fed 4-week-
old mice with tamoxifen for 2 weeks, and 1 week later lung
tumours were collected from Pik3caWT/ or Pik3caRBD/
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Figure 6 | Reelin expression in tumours in mice and clinical data sets. (a) Reln expression in lung tumours from 7-week-old Pik3caWT/flox, Pik3caRBD/flox,
Pik3caWT/ Pik3caRBD/ mice treated and untreated with tamoxifen. All these mice harbour an oncogenic mutation in Kras so they develop lung tumours.
Tumours were collected 1 week after the end of tamoxifen treatment. Actin expression was used as an internal control for normalization. (b) E-cadherin
expression in lung tumours from 7-week-old Pik3caWT/flox, Pik3caRBD/flox, Pik3caWT/ Pik3caRBD/ mice treated and untreated with tamoxifen. Tumours
were collected 1 week after the end of tamoxifen treatment. Actin expression was used as an internal control for normalization. (c) Representative images
of Reln and E-cadherin staining of lung sections from Pik3caWT/ Pik3caRBD/ mice. (d) Plot representing human RELN expression values from patients
with the tumour types indicated in the figure. (e) Kaplan–Meier graph showing overall survival for lung adenocarcinoma patients with low and high
expression of RELN. High and low RELN expression was divided by median.
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animals and RNA was extracted. We observed that after
disruption of the RAS-PI3-Kinase interaction, Reelin expression
in tumours from Pik3caRBD/ mice was some fivefold higher
than in Pik3caWT/ mice (Fig. 6a). Similarly, we found an
increase in E-cadherin expression in Pik3caRBD/ mice after
tamoxifen treatment (Fig. 6b). We then determined whether
RELN was also expressed in healthy lungs. We detected RELN
expression in both Pik3caWT/ and Pik3caRBD/ mice lungs,
although expression in Pik3caRBD/ mice lungs was higher than
in WT as observed in our MEFs and in tumours (Supplementary
Fig. 6a). Immunohistochemistry studies also showed an increase
in RELN and E-cadherin in lung tumour sections from
Pik3caRBD/ mice when compared with Pik3caWT/ mice
(Fig. 6c). At this time point, tumours are partially regressing40.
In clinical data sets, we evaluated expression of the human
Reelin gene (RELN) in various cancer cell types using microarray
data from Oncomine to assess whether RELN expression is
reduced in cancers. We looked for data sets in which Reelin
expression was downregulated in tumours compared with healthy
tissue with a P value below 0.05. Several studies matched these
criteria (see list in ‘Methods’ section), confirming that in several
tumour types RELN expression is statistically significantly
decreased when compared with their normal tissue counterparts
(Fig. 6d).
Furthermore, we analysed the association between RELN
expression and patients’ overall survival using the KM-plotter
database (http://kmplot.com)42. This database utilizes gene
expression data and relapse free, and overall survival
information from Gene Expression Omnibus (GEO)
(Affymetrix microarrays only), European Genome-phenome
Archive (EGA) and The Cancer Genome Atlas (TCGA),
integrating gene expression and clinical data. We selected data
from lung adenocarcinoma patients (n¼ 720) and split samples
between high and low expression of RELN by median, and
explored whether high expression of RELN conferred an overall
survival advantage. As shown in Fig. 6e, low expression was
significantly associated with patients’ poor survival, indicating
that loss of RELN expression had a negative influence on clinical
outcomes. Furthermore, when we explored RELN expression
levels in patients with stage I disease, we observed an even
stronger survival advantage of patients with higher RELN
expression (Supplementary Fig. 6b). The hazard ratio between
high and low RELN expression was 0.64 for all lung
adenocarcinoma, and 0.31 for stage I disease. However, for
patients with stage II or higher disease, RELN expression did not
significantly correlate with outcome (hazard ratio 0.92 or higher).
We also examined survival advantage in breast cancer patients
(n¼ 3554) and found that high expression of RELN was
associated with a better relapse-free survival (Supplementary
Fig. 6c). Again, this advantage was even higher for patients with
grade 1 disease histology (Supplementary Fig. 6d), with hazard
ratio between high and low RELN expression of 0.71 for all breast
carcinoma and 0.53 for grade 1 disease. The discrimination based
on RELN expression was lost in grade 2 and higher disease
(hazard ratio 0.85 or higher). These data suggest that high
expression of RELN at early stages of disease is a good prognostic
factor. However at later stages of disease other factors or
additional mutations in the tumours could overtake the effect
of RELN making this pathway less relevant.
Discussion
Metastasis remains the major driver of mortality in patients with
cancer, despite decades of therapeutic development and testing.
Limiting tumour invasion and metastasis through novel cancer
therapeutics could slow their dissemination leading to improved
clinical outcomes. A good understanding of the molecular
processes governing cell migration and invasion might lead to
the development of new anti-metastatic therapies that could
provide additional reductions in patient morbidity and mortality.
In this study, we have attempted to understand better the role
that RAS signalling through PI3-Kinase has in cell motility. We
generated immortalized mouse embryo fibroblasts from a mouse
model harbouring mutations in the Pi3kca gene encoding the
catalytic p110a isoform that block its interaction with RAS
(ref. 16) and found that preventing RAS/p110a binding abrogates
cell migration in response to EGF, HGF, insulin or oncogenic
RAS signalling.
Disruption of RAS binding to PI3-kinase impairs Rac
activation in response to EGF stimulation but not PDGF,
corresponding with the behaviour observed in random migration
assays, suggesting that loss of Rac activation is involved in the
decrease of migration observed in the RBD-mutant cells after
EGF treatment. It has been shown that PI3-Kinase is involved in
tumour cell motility and invasion mainly through the regulation
of Rho GTPases43,44 and that RAS can cause Rac activation via
PI3-Kinase inducing actin cytoskeleton rearrangement. Inhibition
of PI3K activity blocks RAS induction of membrane ruffling,
while activated PI3K is sufficient to induce membrane ruffling,
acting through Rac (ref. 45). We also found that disruption of
RAS and PI3-Kinase binding greatly increased stabilization of
microtubules. This has been proven to be due to defective Rac
activation as expression of active Rac (RacV12) in Pik3caRBD cells
decreases microtubule stabilization back to levels observed in
control cells. Involvement of Rac in microtubule dynamics has
been previously observed to involve regulation the microtubule-
destabilizing protein stathmin46. Expression of RacV12 also
rescued the migration defect observed after disruption of
RAS-p110a binding, although not to the levels in p110a wild-
type cells; this could reflect the fact the involvement of other
pathways, or the possibility that the GTPase defective RacV12
mutant does not adequately mimic the role of endogenous Rac
protein activated by normal EGF-induced signalling mechanisms.
Expression analysis data showed a striking increase in the
expression of RELN after disruption of RAS binding to p110a.
Reelin is an extracellular multifunctional protein controlling
migration, growth, maturation, and synaptic activity in the
developing and adult brain47–49. A major function of Reelin
appears to be to act as a stop signal for migrating neuronal cell
populations during brain development, and it is this activity that
largely accounts for the abnormal reeling gait (‘reeler’)
neurological phenotype of Reelin defective mice. Reelin is also
expressed in peripheral tissues, including the liver, intestine,
kidney, adrenal glands and pancreas, suggesting an additional role
for Reelin in development and possibly in structural maintenance
of these organs50,51. In this regard it has been recently described
that Reelin plays a fundamental role in the correct homeostasis of
the intestine52,53.
The mechanisms controlling Reelin expression are poorly
understood and have been mostly gathered from tumours and
from post-mortem schizophrenia brains. In both cases it was
found that loss of Reelin expression is the consequence of a
Dnmt1-mediated hypermethylation of the corresponding
promoter30,54–56. However, the mechanisms governing Reelin
expression in a normal physiological situation may be different,
or additional regulatory mechanisms may exist. Here we have
shown that RAS binding to p110a regulates expression of Reelin
by decreasing the half-life of its mRNA. The PI3-Kinase pathway
is involved in the control of gene expression regulating the
activity of RNA-binding factors that stabilize mRNA31–33.
Additionally, it has been shown that Reelin expression is also
controlled by the binding of the microRNA miR-128 to the
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30-UTR region of Reelin mRNA57. Future experiments are
required to fully address how RAS-PI3K signalling might be
controlling Reelin mRNA stabilization.
Increased Reelin expression correlates with the decrease in
migration we observed in response to EGF. However, it does not
seem to have any effect on migration in quiescent cells or after
PDGF stimulation. We believe this effect is due to differences in
the tyrosine kinase receptor activation. Whereas EGF receptor
activation engages both RAS and tyrosine-phosphorylated
adaptor protein/p85 regulatory subunit binding to signal to
PI3K, PDGF receptor binds directly to p85 and controls PI3K
in a mechanism that is independent of RAS (ref. 58).
These differences in activation might account for the
differences observed in migration after stimulation by different
growth factors. Thus, although RAS-PI3K binding regulates the
expression of RELN, involvement of Reelin in migration will
depend on the upstream activator.
Besides the role of Reelin in normal physiological conditions,
loss of Reelin expression has been linked to tumour development
and metastasis formation. This loss of expression correlates
with poor prognosis in cancers and increased metastatic
potential29,30,56,59. We have also confirmed that lung tumours
lacking the RAS-PI3K interaction present an increase in Reelin
and E-cadherin expression. It is well accepted that loss of
E-cadherin is associated with increased cell migration and
invasion60,61. This loss appears to be a key event in the
acquisition of invasive capacity, because re-expression of
E-cadherin suppresses the invasion of tumour cells in vitro62.
Although a metastatic model of RAS-induced lung cancer would
be necessary to test the role of Reelin and E-cadherin
upregulation in tumour invasion and metastasis formation,
these results suggest that RAS-PI3K regulation of Reelin might
be part of a mechanism by which cancer cells could gain the
enhanced motility necessary to metastasize. Finally, we found that
both lung adenocarcinoma and breast carcinoma patients have
better survival expectancy when Reelin levels in their tumours
were higher. This effect is only seen for the lowest grade tumours,
suggesting that while Reelin may be able to constrain tumour
spread; this ability can be overcome by other mechanisms of
tumour progression.
Overall our data demonstrate a specific role for the interaction
of RAS with PI3-Kinase in the regulation of cell migration.
RAS-PI3-Kinase regulation of Reelin is essential for proper cell
migration and failure of regulation of this pathway might result in
loss of Reelin expression and increased migratory phenotype.
Ways to re-express Reelin in tumours, or to suppress Rac
activation in tumours lacking Reelin expression, might be
explored as a therapeutic approach to reduce cancer cell
migration and to improve patient outcome.
Methods
Tissue culture. Primary cultures of MEFS were generated in house as previously
described63 (all clones tested negative for mycloplasma). Immortalized cultures
of MEFs were generated as described by Gupta et al.16. MEFs were cultured in
Dulbecco’s modified Eagle’s medium supplemented with FBS (10% FBS; Hyclone,
Logan, UT, USA), glutamine (2mM), penicillin (100Uml 1) and streptomycin
(100 mgml 1). Cultures were grown in a humidified CO2 (10%) atmosphere at
37 C.
Random migration and wound-healing assays. For random migration assays,
cells were seeded in 24-well plates and 24 h later they were serum-starved
overnight. Fresh Dulbecco’s modified Eagle’s medium containing 0.2% FBS with or
without the desired growth factor at the specific concentration was added (FBS
10%; EGF 20 ngml 1; PDGF 20 ngml 1; FGF2 10 ngml 1; HGF 10 ngml 1;
insulin 100 ngml 1).
For wound-healing assays PIK3CAWT and PIK3CARBD cells were seeded at
confluency in 6-well plates and subjected to scratch wounding. A wound track was
introduced by scraping the cell monolayer with a yellow pipette tip (10ml). Media
was removed and wells were washed with PBS to remove unattached and dead
cells. Media with or without the desired growth factor at the specific concentration
was then added (FBS 10%; EGF 20 ngml 1).
For both assays duplicates of each condition and genotype were prepared.
Time-lapse imaging was carried out for 18 h. One image was taken every 10min at
three different positions within the same well using a Nikon microscope driven by
Metamorph (Molecular Devices, Chicago, IL, USA). A total of 90 cells per
condition were tracked using CellTrack. Tracks were then analysed using a
previously described Mathematica notebook64.
RAS and Rac-GTPase activation assays. GTP-bound RAS/Rac was assayed
using a commercial kit from Millipore (Billerica, MA, USA) and following the
manufacturer’s protocol. For quantitative western blotting, bound primary
antibodies were detected by secondary conjugates compatible with infrared
detection at 700 and 800 nm, and membranes were scanned using the Odyssey
Infrared Imaging System (Odyssey, LICOR). Finally GTP-activated protein levels
were normalized to total protein and plotted.
Microarrays. The Agilent Whole Mouse Genome Microarray platform
(G4122F; Agilent Technology) and one-colour experimental design were used. This
microarray contains 41,174 mouse probes (features) and 93 control spots, with
each feature comprised of a single 60-mer oligonucleotide probe. These probes
mapped to 33,978 individual mouse transcripts (sequence IDs provided by the
manufacturer). Sample labelling, hybridization to microarrays, scanning and
calculation of normalized expression ratios was carried out at Oxford Gene
Technology microarray facility. Sample labelling and hybridization were performed
according to protocols specified by the manufacturer One-Color Microarray-Based
Gene Expression Analysis. Briefly, 1 mg of total RNA and Cy3-labelled CTP
fluorescent dyes were used to generate fluorescent cRNA with One-Color
Microarray-Based Gene Expression Analysis (Quick Amp Labelling) v5.7 (Agilent
Technologies, Palo Alto, CA, USA). For hybridization, 1.65 mg of Cy3-labelled
cRNA was added on microarray slide for 17 h at 65 C at 10 r.p.m. using the
Hybridization Oven kit procedure provided by Agilent Technologies. After
hybridization, the slides were then washed per Agilent’s SSPE wash protocol, dried
and scanned at 5 mm resolution with a G2505C DNA microarray scanner (Agilent
Technologies). Data were then extracted from images by the Feature Extraction
software version 10.5.1.1, protocol GE1_105_Jan09 (Agilent Technologies).
The expression data was log transformed and quantile normalized using
Agilent’s gProcessedSignal chip quantification value as a measure of expression.
Control probes were removed before normalization. Genotype-dependent
transcriptional changes were identified by linear model. The model was fitted
across all samples and the t-statistics moderating by empirical Bayes shrinkage.
Significant transcriptional changes were selected using a 0.05 FDR threshold.
The analysis was carried out using the Limma package from Bioconductor 2.6
(ref. 65) using default parameters. Annotation was obtained from the mgug4122a
annotation package. The RNA-seq data have been deposited with Gene Expression
Omnibus, GEO accession number GSE77843.
Invasion assays. Invasion assays were carried out as previously described22.
Analysis of the invasion assay image data was carried out using a custom developed
Mathematica (Wolfram Research) notebook, which generates aligned normalized
invasion profiles for each three-dimensional image, determines an invasion value
from each profile and performs an analysis of variance on the plate invasion data.
In more detail each three-dimensional image is treated in the following way.
The image is imported and the Otsu method threshold value is subtracted. The
resultant cell intensities are summed in x and y generating a total cell intensity with
z profile of the image. The collected intensity profiles are co-aligned in z using their
maxima by padding individual profiles with zero valued z-positions as necessary.
This alignment corrects for variation of the cell layer position within the image
stacks and allows a single-invasion horizon applicable to all profiles. Selection of an
appropriate z-position as the invasion horizon is by inspection of the collected
z-profiles. Invasion values for each image are calculated as the proportion of total
intensity located beyond the invasion horizon. The sets of experimental group data
are compared with the control group data using analysis of variance.
Western blotting. Protein samples extracted from total cell lysates using RIPA
buffer were subjected to electrophoresis commercial SDS polyacrylamide gels
(Novex, Life Technologies) under reducing conditions, and subsequently
transferred to polyvinylidene difluoride membranes (Millipore Immobilon-P).
Protein bands were detected using the ECS system (GE Healthcare) Antibodies
directed against Phospho-AKT (Ser473; 4060), Phospho-S6 (2211), Pan-Akt
(2920), Cdh1 (3195), actin (4968) and tubulin (2125) were purchased from Cell
Signalling Technologies. Antibody against Reln was obtained from R&D. Antibody
against acetylated a-tubulin (ab2460) was obtained from Abcam. Antibodies
against Rac (05–389), Ras (05–516) and Glu-tubulin (AB3201) were purchased
from Millipore. All antibodies were used in a 1:1,000 dilution. Full blots scans are
shown at the end of Supplementary Information.
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Immunofluorescence. Cells were fixed using 4% paraformaldehyde, permeabilized
with 0.1% Triton X-100 and blocked for 1 h with 3% BSA in PBS before incubation
with the primary antibodies. To stain actin fibres, Alexa Fluor 488 Phalloidin
(Invitrogen) was directly added to the primary antibody mixture. Alexa Fluor
488- or Alexa Fluor 594-conjugated secondary antibodies (Invitrogen) were used to
detect the indicated proteins at a 1:500 dilution. Cells were counterstained with
DAPI (Sigma). Images were taken using a Zeiss LSM510 confocal microscope.
Transwell assays. Transwell invasion assays were carried out using the
commercially available kit CytoSelect 24-Well Cell Invasion Assay, Basement
Membrane (Cell Biolabs, San Diego, CA, USA) and following the manufacturer
instructions. EGF (50 nM) was used as a chemo-attractant to encourage cell
migration.
Short interfering RNA transfection. Cells were reverse-transfected with 25 nM of
Dharmacon SMARTpools in 24-well plates using Dharmafect 4 reagent (Lafayette,
CO, USA) following manufacturer instructions. Efficiency of all silencing
experiments was checked by quantitative PCR and silencing of480% of the target
gene was achieved (data not shown).
Real-time quantitative PCR. Total RNA was extracted using QIAshredder
and RNAeasy mini Kit from Qiagen (Qiagen, Hilden, Germany), according to
manufacturer’s protocol. Total RNA (1mg) was used as template for reverse
transcription reaction (High Capacity cDNA Reverse Transcription Kit, Life
Technologies Ltd, Paisley, UK). Single stranded complementary DNA products
were then analysed using the 7900HT Fast Real-Time PCR system (Applied
Biosystems), and specific primers for Reelin (QT00093569), E-cadherin
(QT00121163), Dab1 (QT00318941), Rap1 (QT02532915) and actin (QT01136772;
Quantitect primer Assay, Qiagen, Hilden, Germany).
Clinical data analysis. Microarray expression data from Oncomine database were
analysed to determine if loss of RELN expression was associated with tumour
development. Statistical significant data set with P values below 0.0001 in which
RELN expression was downregulated 41.5 times were selected (we selected: the
Okayama data set for lung adenocarcinoma (GSE31210); the Grutzmann data
set for pancreatic ductal adenocarcinoma (E-MEXP-950); TCGA data set
(http://tcga-data.nci.nih.gov/tcga/) for invasive ductal breast carcinoma, colorectal
carcinoma and glioblastoma; Mas (GSE14323) and Roessler (GSE14520) data sets
for hepatocellular carcinoma; Talantov dataset for melanoma (GSE3189); Ginos
data set for Head and Neck carcinomas66; and Sanchez-Carbayo for infiltrating
bladder carcinoma67). Expression data values for each individual study were
plotted using GraphPad PRISM version 5.b.
Survival analysis. Kaplan–Meier graphs were constructed using the KM-plotter
database (http://kmplot.com/)42. This database contains gene expression data and
relapse free and overall survival information from GEO (Affymetrix microarrays
only), EGA and TCGA. The database is handled by a PostgreSQL server, which
integrates gene expression and clinical data simultaneously. To analyse the
prognostic value of RELN, patient samples were split into two groups according to
mean expression value. The two patient cohorts were compared by a Kaplan–Meier
survival plot, and the hazard ratio with 95% confidence intervals and log rank
P value were calculated.
Statistical analysis. Significance was determined also with GraphPad Prism 5
software using the Student’s t-test unless stated otherwise.
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